Australia's most trusted
source of pharma news
Friday, 06 March 2026
Posted 6 March 2026 AM
MSD has unveiled a major restructure - splitting its Human Health Business into two separate units - but the shakeup will wash over Australia and New Zealand, with little impact on the local operations.
The company is creating an 'Oncology Business Unit' and a 'Specialty, Pharma & Infectious Diseases Business Unit', reorganising its primary Human Health Business into two distinct divisions.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.